nocodazole has been researched along with piplartine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madala, HR; Mikelis, C; Punganuru, SR; Samala, R; Srivenugopal, KS; Venugopal, SN | 1 |
| Meegan, MJ; Nathwani, S; O'Boyle, NM; Twamley, B; Zisterer, DM | 1 |
2 other study(ies) available for nocodazole and piplartine
| Article | Year |
|---|---|
Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Chemistry Techniques, Synthetic; Dioxolanes; Drug Design; Female; Genes, Tumor Suppressor; Glutathione; Humans; Microtubules; Mutation; Reactive Oxygen Species; Stilbenes; Tumor Suppressor Protein p53 | 2016 |
Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Dioxolanes; Female; Humans; MCF-7 Cells; Microtubules; Models, Molecular; Piperidones; Reactive Oxygen Species; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2017 |